在肝硬化中,miR-7-5p的诊断价值和预后效应
Wenchao Li1, Yanbing Tian1, Lijing Jing1
1Hepatology Department of integrated Chinese and Western medicine, Xingtai People's Hospital, Xingtai, China.
Digestive diseases (Basel, Switzerland)
|August 15, 2025
概括
微RNA-7-5p (miR-7-5p) 在肝硬化患者中被上调,并显示出作为诊断生物标志物的潜力. 较高的miR-7-5p水平与肝硬化病的预后和生存率较差相关.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝硬化是全球重要的健康问题.
- 早期诊断和预后评估对于患者管理至关重要.
- 积极寻找肝硬化诊断和预后的生物标志物.
研究的目的:
- 在肝硬化患者中研究微RNA-7-5p (miR-7-5p) 水平.
- 评估miR-7-5p和肝功能指标之间的相关性.
- 评估miR-7-5p在肝硬化中的诊断和预后价值.
主要方法:
- 定量实时PCR (qRT-PCR) 用于测量患者和健康对照中的miR-7-5p水平.
- 皮尔森相关性分析,以检查与肝功能标志物 (ALT,AST,PT,INR,TBil,白蛋白) 的关系.
- 接收器运行特征 (ROC) 曲线分析用于诊断意义和Cox回归/Kaplan-Meier用于预后评估.
主要成果:
- 与健康对照组相比,miR-7-5p在肝硬化患者的血清中显著上调.
- miR-7-5p水平与ALT,AST,PT,INR和TBil正相关,与专蛋白负相关.
- 经过ROC分析,曲线下的面积 (AUC) 为0.862,表明诊断准确度很高. 高水平的miR-7-5p与较低的存活率有关,并被确定为独立的预后因素.
结论:
- miR-7-5p作为一个有前途的生物标志物用于诊断肝硬化.
- miR-7-5p有效预测患者的预后和生存结果.
- 这种微RNA可以帮助早期诊断和个性化治疗策略肝硬化患者.
更多相关视频
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:23Cirrhosis I: Introduction
28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
01:24Cirrhosis II: Pathophysiology
41
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
41